Clinical and Translational Science Award
临床和转化科学奖
基本信息
- 批准号:9309130
- 负责人:
- 金额:$ 934.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAcademic Medical CentersAchievementApplications GrantsAreaAwardBiomedical ResearchClinicalClinical InvestigatorClinical ResearchClinical SciencesClinical and Translational Science AwardsCollaborationsCommunitiesConsultationsDentalEducationEducational StatusEnsureEnvironmentEthicsEvolutionFacultyFreedomFundingGiftsGoalsGrantHealthHealth ProfessionalHospitalsIndividualInformation DisseminationInformation TechnologyInpatientsInstitutesInvestigationKnowledgeLaboratoriesLeftLinkMedical ResearchMedical centerMedicineMethodologyMissionNational Center for Research ResourcesNew YorkNursesNursing ResearchOutpatientsParticipantPatientsPhysiciansPrecision Medicine InitiativePresbyterian ChurchPrivacyProcessProviderPublic Health SchoolsRecording of previous eventsRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResearch SupportResearch TrainingResourcesRewardsSchool NursingScienceScientistSourceSpeedStructureStudentsSurgeonSystemTestingTextTherapeuticTimeTrainingTraining SupportTranslational ResearchTrustTrusteesUnited States National Institutes of HealthUniversitiesVisionWashingtonbasecareerclinical carecollegecostimprovedinnovationinsightinterestmembermultidisciplinarynext generationnovelnovel therapeuticsprecision medicineprogramssenior facultyskillssuccesstooltranslational scientistweb site
项目摘要
Contact PD/PI: GINSBERG, HENRY N
OVERALL ABSTRACT
Our CTSA Hub is situated in the Irving Institute for Clinical and Translational Research (Irving Institute) of
Columbia University (CU), and based at the CU Medical Center (CUMC) in Northern Manhattan (NM). The CU
College of Physicians and Surgeons (P&S), Mailman School of Public Health (MSPH), College of Dental
Medicine (CDM), and School of Nursing (SON) are all at CUMC together with major components of New York
Presbyterian Hospital (NYP) and the New York State Psychiatric Institute (NYSPI). The vision of the Irving
Institute is: 1) to transform the culture of biomedical research enabling CUMC investigators to develop new
treatments faster and deliver those treatments to patients more efficiently, effectively, and safely than ever
before; 2) to utilize medical research advances to benefit patients and the community, converting knowledge
into practice; and 3) to recruit, train, support and nurture the next generation of clinical and translational
investigators in multi- and interdisciplinary team science environments. Since first receiving CTSA funding in
2006, we embraced a vision that would impact maximally on a) individuals, particularly junior faculty and
trainees, b) groups of faculty and trainees working in common areas of interest but often in relative isolation,
and 3) the institutional culture. We believed that this bottom-up approach was necessary if we were to move
CUMC from a system that rewarded individual effort more than the achievements of groups. After nine years,
we are certain that we have changed the environment significantly, and that CUMC and NYP both understand
that multidisciplinary team efforts are essential for success in this era of greater complexity both in science and
in clinical care. Additionally, we all have come to understand that only by engaging our patients early in the
research process, particularly those individuals in the communities of Northern Manhattan (NM), will we gain
their trust and enthusiasm, two keys to their participation in the revolution generated by Precision Medicine.
Our aim is to expand, enhance, and improve the Irving Institute's CTSA Hub, to ensure that we create an
outstanding environment where junior and senior faculty, trainees, clinical research coordinators, nurses,
support staff, and patients, particularly members of the underserved and underrepresent communities of NM
are all engaged in, and benefit from, our efforts to meet the exciting and unique opportunities afforded by the
CU/NYP Precision Medicine Initiative and the extraordinary advancements in information technologies, `omics',
and therapeutic possibilities. Innovations and achievements at our Hub will be disseminated for the benefit of
our local neighboring Hubs and the CTSA Hub Network.
Project Summary/Abstract Page 162
Contact PD/PI: GINSBERG, HENRY N
Narrative
The Clinical and Translational Science Award (CTSA) allows Columbia University to support novel programs
whose goal is to speed the transition from scientific discoveries made in the laboratory toward new therapies.
We will conduct and support research, training, health information dissemination, and other programs with
respect to translational science. We will facilitate the training of scholars from diverse backgrounds
underrepresented in translational science who are knowledgeable about and available to focus on translational
science later in their careers.
联系人 PD/PI:GINSBERG, HENRY N
总体摘要
我们的 CTSA 中心位于美国欧文临床和转化研究所(欧文研究所)
哥伦比亚大学 (CU),位于曼哈顿北部 (NM) 的 CU 医学中心 (CUMC)。 CU
内外科医学院 (P&S)、梅尔曼公共卫生学院 (MSPH)、牙科学院
医学院 (CDM) 和护理学院 (SON) 均位于 CUMC 以及纽约的主要组成部分
长老会医院 (NYP) 和纽约州精神病研究所 (NYSPI)。欧文的愿景
研究所的目标是: 1) 转变生物医学研究文化,使 CUMC 研究人员能够开发新的
治疗速度更快,并比以往更高效、有效和安全地为患者提供治疗
前; 2)利用医学研究进展造福患者和社区,转化知识
付诸实践; 3) 招募、培训、支持和培养下一代临床和转化人才
多学科和跨学科团队科学环境中的研究人员。自首次获得 CTSA 资助以来
2006 年,我们提出了一个愿景,该愿景将最大程度地影响 a) 个人,特别是初级教师和
受训者,b) 在共同感兴趣的领域工作但通常相对孤立的教师和受训者群体,
3)制度文化。我们相信,如果我们要采取行动,这种自下而上的方法是必要的。
CUMC 的体系对个人努力的奖励多于对团体成就的奖励。九年后,
我们确信我们已经显着改变了环境,并且 CUMC 和 NYP 都明白
在这个科学和技术都更加复杂的时代,多学科团队的努力对于成功至关重要
在临床护理中。此外,我们都已经认识到,只有尽早让患者参与进来
研究过程,特别是那些生活在北曼哈顿 (NM) 社区的个人,我们将获得
他们的信任和热情是他们参与精准医学革命的两个关键。
我们的目标是扩大、增强和改进欧文研究所的 CTSA 中心,以确保我们创建一个
优秀的环境,初级和高级教师、实习生、临床研究协调员、护士、
支持人员和患者,特别是新墨西哥州服务不足和代表性不足的社区的成员
我们所有人都参与并受益于我们的努力,以迎接由
CU/NYP 精准医学计划以及信息技术、“组学”、
和治疗的可能性。我们中心的创新和成就将被传播,造福于
我们当地的邻近枢纽和 CTSA 枢纽网络。
项目总结/摘要第 162 页
联系人 PD/PI:GINSBERG, HENRY N
叙述
临床和转化科学奖 (CTSA) 允许哥伦比亚大学支持新颖的项目
其目标是加速从实验室科学发现向新疗法的转变。
我们将开展并支持研究、培训、健康信息传播和其他项目
尊重转化科学。我们将促进来自不同背景的学者的培训
在转化科学领域中代表性不足,但他们了解并能够专注于转化
在他们的职业生涯后期从事科学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Muredach P Reilly其他文献
Single-cell multimodal profiling of monocytes reveals diverse phenotypes and alterations linked to cardiovascular disease risks
单核细胞的单细胞多模式分析揭示了与心血管疾病风险相关的多种表型和变化
- DOI:
10.1101/2024.02.18.580913 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Alexander C. Bashore;Chenyi Xue;Eunyoung Kim;Hanying Yan;Lucie Y. Zhu;Huize Pan;Michael D Kissner;Leila S Ross;Hanrui Zhang;Mingyao Li;Muredach P Reilly - 通讯作者:
Muredach P Reilly
1008-184 The effects of pravastatin and atorvastatin on markers of oxidant stress in vivo
- DOI:
10.1016/s0735-1097(04)91877-3 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Bonnie Ky;Megan L Wolfe;Anne Burke;Philippe O Szapary;Muredach P Reilly;Jennifer B Dykhouse;Leanne T Bloedon;Garret A FitzGerald;Daniel J Rader - 通讯作者:
Daniel J Rader
Muredach P Reilly的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Muredach P Reilly', 18)}}的其他基金
Smooth muscle cell-derived cell fates and cellular interactions in atherosclerotic plaque stability in disease progression and regression.
平滑肌细胞衍生的细胞命运和细胞相互作用在疾病进展和消退中动脉粥样硬化斑块的稳定性。
- 批准号:
10567844 - 财政年份:2023
- 资助金额:
$ 934.07万 - 项目类别:
Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk
鉴定导致动脉粥样硬化斑块稳定性和心血管疾病风险的平滑肌细胞基因
- 批准号:
10720225 - 财政年份:2023
- 资助金额:
$ 934.07万 - 项目类别:
Human LincRNAs in Macrophage Biology and Related Cardiometabolic Diseases
巨噬细胞生物学和相关心脏代谢疾病中的人类 LincRNA
- 批准号:
9402855 - 财政年份:2017
- 资助金额:
$ 934.07万 - 项目类别:
Human LincRNAs in Macrophage Biology and Related Cardiometabolic Diseases
巨噬细胞生物学和相关心脏代谢疾病中的人类 LincRNA
- 批准号:
9983136 - 财政年份:2017
- 资助金额:
$ 934.07万 - 项目类别:
Human LincRNAs in Macrophage Biology and Related Cardiometabolic Diseases
巨噬细胞生物学和相关心脏代谢疾病中的人类 LincRNA
- 批准号:
9531432 - 财政年份:2017
- 资助金额:
$ 934.07万 - 项目类别:
相似海外基金
Building a Systems Approach to Community Health and Health Equity for Academic Medical Centers
为学术医疗中心建立社区健康和健康公平的系统方法
- 批准号:
9348616 - 财政年份:2016
- 资助金额:
$ 934.07万 - 项目类别:
Building a Systems Approach to Community Health and Health Equity for Academic Medical Centers
为学术医疗中心建立社区健康和健康公平的系统方法
- 批准号:
9212055 - 财政年份:2016
- 资助金额:
$ 934.07万 - 项目类别:
A CONFERENCE ON THE 'CRISIS' OF ACADEMIC MEDICAL CENTERS
关于学术医疗中心“危机”的会议
- 批准号:
6335654 - 财政年份:2000
- 资助金额:
$ 934.07万 - 项目类别:














{{item.name}}会员




